Brain Magnetic Resonance Imaging at 3.0 Tesla in neurodegenerative parkinsonism – a pilot study

Medizinische Universität Innsbruck,Department für Neurologie0 个研究点目标入组 120 人开始时间: 2011年10月14日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. clinical diagnosis of PD, MSA or PSP obtained by a neurologist according to published clinical diagnostic criteria;
•2. the patient has the ability to communicate well with the investigator and comply with the requirements of the study;
•3. written informed consent is obtained;
•healthy controls:
•1. the subject has the ability to communicate well with the investigator and comply with the requirements of the study;
•2. written informed consent is obtained;

•1. History of other neurological or psychiatric disorders or conditions;
•2. the subject has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th Edition (DSM-IV);
•3. the subject is pregnant;
•4. the subject is unsuitable for an MRI study (e.g. Pacemakers);
•healthy controls:
•1. History of neurological or psychiatric disorders or conditions;
•2. the subject has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th Edition (DSM-IV);
•3. the subject is pregnant;
•4. the subject is unsuitable for an MRI study

发起方

Medizinische Universität Innsbruck,Department für Neurologie